Biology and pathogenesis of lymphocytic choriomeningitis virus infection

Current Topics in Microbiology and Immunology

Volumn 263, Issue , 2002, Pages 83-117

  Oldstone, M B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GROWTH HORMONE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NEWBORN; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS MENINGITIS; VIRUS PATHOGENESIS;

ANIMALIA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 0036185899     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56055-2_6     Document Type: Review

References (136)

1. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes
2. Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: Role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains
3. Immune therapy of a persistent and disseminated viral infection
4. Organ-specific selection of viral variants during chronic infection
5. Molecular basis of organ-specific selection of viral variants during chronic infection
6. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: Role in suppression of cytotoxic T lymphocyte response and viral persistence
7. Genetic analysis of in vivo-selected viral variants causing chronic infection: Importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus
8. Immunosuppression by lymphocytic choriomeningitis virus infection: Competent effector T and B cells but impaired antigen presentation
9. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: Clearance of virus and in vitro properties
10. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus
11. + T-cell-deficient mice
12. Bemerkung zu dem aufsatz von herrn iwanowsky über die mosaikkrankheit der tabakspflanze
13. Defining parameters for successful immunocytotherapy of persistent viral infection
14. Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope
15. Natural variants of cytotoxic epitopes are T cell receptor antagonists for anti-viral cytotoxic T cells
16. Structure of the human class I histocompatibility antigen. HLA-A2
17. Dissecting the molecular anatomy of the nervous system: Analysis of RNA and protein expression in whole body sections of laboratory animals
18. Virus-induced immunosuppression: Immune system-mediated destruction of virus-infected dendritic cells results in generalized immunosuppression
19. Antiviral pressure exerted by HIV-1-specific cytoroxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
20. Lymphocytic choriomeningitis virus
21. The in vivo pathogenicity of different LCMV isolates correlates with binding to putative cellular receptors in vitro and the amino acid sequence of the virion attachment protein GP-1
22. The virology and immunobiology of lymphocytic choriomeningitis virus infection
23. Variants able to cause growth hormone deficiency syndrome are present within the disease-nil WE strain of lymphocytic choriomeningitis virus
24. Disruption of differentiated functions during viral infection in vivo. V. Mapping of a locus involved in susceptibility of mice to growth hormone deficiency due to persistent lymphocytic choriomeningitis virus infection
25. + T cells during an acute virus infection
26. b mutants
27. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
28. Viruses disrupt functions of human lymphocytes: Effects of measles virus and influenza virus in lymphocyte-mediated killing and antibody production
29. Requirement for θ-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease
30. + population
31. Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells
32. Selective disruption of growth hormone transcription machinery by viral infection
33. Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons
34. Competitive selection in vivo by a cell for one variant over another: Implications for RNA virus quasispecies in vivo
35. Role of the major histocompatibility complex in targeting effector T cells into a site of virus infection
36. Virus-induced immunosuppression: Kinetic analysis of the selection of a mutation associated with viral persistence
37. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
38. Persistent infection with lymphocytic choriomeningitis virus enhances expression of MHC class I GP on cultured mouse brain endothelial cells
39. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes
40. An αβ T cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex
41. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction of virus-carrier state in adult mice
42. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers
43. Behavioral effects of persistent lymphocytic choriomeningitis virus infection in mice
44. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
45. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte
46. Dystroglycan inside and out
47. Effect of oncogenic virus on muscle differentiation
48. Lineages in cell differentiation and in cell transformation
49. + T cell memory is associated with reduced bcl-2 and telomerase expression
50. Lymphocytic choriomeningitis infection of mice as a model for the study of latent virus infection
51. Virus-induced behavioral alteration of mice
52. b molecules is controlled by dominant negative elements at peptide non-anchor residues: Implications for peptide selection and presentation
53. Ueber die mosaikkrankheit der tabakspflanze
54. Abrogation of tolerance to a chronic viral infection
55. Viral persistence in neurons explained by lack of major histocompatibility complex class I expression
56. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses
57. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: Interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo
58. Lymphocytic choriomeningitis virus selectively alters differentiated but not housekeeping functions: Block in expression of growth hormone gene is at the level of transcriptional initiation
59. Molecularly engineered vaccine which expresses an immunodominant T cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection
60. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants
61. Virus escape from CTL recognition
62. Pathology of the choroid plexus in spontaneous immune complex disease and chronic viral infections
63. Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus
64. CTL escape viral variants. I. Generation and molecular characterization
65. CTL escape viral variants. II. Biologic activity in vivo
66. Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury
67. Neurotransmitter abnormalities in Borna disease
68. Berichte der kommission zur erforschung der maul und klauenseuche bei dem institut für infektionskrankheiten in Berlin
69. Interaction between antigenically different cells: Virus induced cytotoxicity by immune lymphocytes in vitro
70. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice
71. + cytotoxic T-cell responses during chronic viral infection
72. Genetic basis of viral persistence: Single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist to adult mice
73. Emerging principles for the recognition of peptide antigens by MHC class I molecules
74. Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus
75. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus
76. Functional role of type I and type II interferons in antiviral defense
77. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
78. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure
79. Virus neutralization and virus-induced immune complex disease: Virus-antibody union resulting in immunoprotection or immunologic injury - Two sides of the same coin
80. Virus can alter cell function without causing cell pathology: Disordered function leads to imbalance of homeostasis and disease
81. An old nemesis in new clothing: Viruses playing new tricks by causing cytopathology in the absence of cytolysis
82. Molecular anatomy of viral disease
83. Viral alteration of cell function
84. Molecular anatomy of viral persistence
85. Viruses and diseases of the twenty-first century
86. How viruses escape from cytotoxic T lymphocytes: Molecular parameters and players
87. Perturbation of differentiated functions during viral infection in vivo. I. Relationship of lymphocytic choriomeningitis virus and host strains to growth hormone deficiency
88. Cytoimmunotherapy for persistent virus infection: Unique clearance pattern from the central nervous system
89. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice
90. Disease accompanying in utero viral infection: The role of maternal antibody in tissue injury after transplacental infection with lymphocytic choriomeningitis virus
91. The pathogenesis of cellular injury associated with persistent LCM viral infection
92. Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus
93. Viral perturbation of endocrine function: Disorder of cell function leading to disturbed homeostasis and discase
94. Virus-induced alterations in homeostasis: Alterations in differentiated functions of infected cells in vivo
95. Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes
96. Virus induced immune complex disease: Genetic control of Clq binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus
97. Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice
98. b cytotoxic T lymphocytes
99. + T cells upon acute versus persistent viral infection
100. Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus
101. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
102. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo
103. MHC ligands and peptide motifs: First listing
104. The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2
105. Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: Virulence in guinea pigs is associated with the L RNA segment
106. Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV)
107. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
108. -)
109. Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity
110. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
111. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor α-dystroglycan correlate with viral tropism and disease kinetics
112. TOGA: An automated parsing technology for analyzing expression of nearly all genes
113. Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants
114. A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome
115. Virus induced immunosuppression. I. Age at infection relates to a selective or generalized defect
116. Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus
117. An essential role for type 1 interferon-γ in terminating persistent viral infection
118. Perturbation of differentiated functions during viral infection in vivo. In vivo relationship of host genes and lymphocytic choriomeningitis virus to growth hormone deficiency
119. Role of viral strains and host genes in determining levels of immune complexes in a model system: Implications for HIV infection
120. Persistence of lymphocytic choriomeningitis virus in immune animals and its relation to immunity
121. Perturbation of differentiated functions in vivo during persistent viral infection. III. Decreased growth hormone mRNA
122. + T cells during acute infection with lymphocytic choriomeningitis virus
123. Tissue-mediated selection of viral variants: Correlation between glycoprotein mutation and growth in neuronal cells
124. Vaccination to treat persistent viral infection
125. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus
126. Immune function in mice lacking the perforin gene
127. The immune response to viruses
128. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus
129. Cloning and expression analyses of mouse dystroglycan gene: Specific expression in maternal decidua at the periimplantation stage
130. b at 2.4 Å resolution: Implications for antigen-determinant selection
131. + lymphocytes during an acute viral infection
132. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system
133. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D